Originally posted by the Voice of America. Voice of America content is produced by the Voice of America, a United States federal government-sponsored entity, and is in the public domain. Sandworm Blood Could Help Coronavirus Victims VOA News Two French hospitals are poised to start experimental treatment with sandworm blood of patients suffering of respiratory problems caused by the new coronavirus. Doctors atPitie-SalpetriereHospital and Georges Pompidou Hospital in Parisare going to test in coming dayswhether it is safe to injectthe sandworm blood,directly in human blood,hoping toincrease oxygen levels in the tissue ofinfectedpatients. The French government drug agency ANSMapprovedthephaseoneclinical trialonMarch 27and thegovernment ethics committeecleared it onApril 4. Biology researcher FranckZal,the CEO of biotechnology companyHemarina,observed years ago that sandworms, also known aslugworms,couldsurvivedon land and in water. "I observed that the worm only breathes when it is in the sea, and when it is in the sand it stops breathing for 6 hours. So,I discoveredthat this molecule is its little oxygen tank that allows it to hold six hours until the next high tide,"Zalsaid. The treatmentZalsubsequently inventedhas been applied tokidney transplant patients and improvedthe oxygen levels of the organs. Hemarinanowhas a worm farm on the Atlantic island ofNoirmoutier. Thetest will start with 10 coronavirus patientswho are near deathand will not include acontrol group. If the clinical trial goes to the next phase, it will include a control group. The treatment willbe administered one patient at a time and will be givenonlyto thosewhose families have given consent. French doctors admit that thetreatment is unusual andin theearly stage of testing, butdue tourgent need to findsolutions for the new COVID-19, they believeitisworth trying. France had reported more than 8,000 deaths related tothe coronavirus as of Sunday.'¯ .